Frank A Damelio - Net Worth and Insider Trading

Frank A Damelio Net Worth

The estimated net worth of Frank A Damelio is at least $16 Million dollars as of 2024-04-24. Frank A Damelio is the Executive Vice President of Pfizer Inc and owns about 337,392 shares of Pfizer Inc (PFE) stock worth over $9 Million. Frank A Damelio is the Director of Humana Inc and owns about 20,634 shares of Humana Inc (HUM) stock worth over $7 Million. Frank A Damelio is also the Director of Zoetis Inc and owns about 5,000 shares of Zoetis Inc (ZTS) stock worth over $747,800. Details can be seen in Frank A Damelio's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Frank A Damelio has not made any transactions after 2019-07-02 and currently still holds the listed stock(s).

Transaction Summary of Frank A Damelio

To

Frank A Damelio Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Frank A Damelio owns 5 companies in total, including Pfizer Inc () , Zoetis Inc () , and Humana Inc () among others .

Click here to see the complete history of Frank A Damelio’s form 4 insider trades.

Insider Ownership Summary of Frank A Damelio

Ticker Comapny Transaction Date Type of Owner
Pfizer Inc 2019-07-02 Senior Vice President
Zoetis Inc 2013-08-15 director
Humana Inc 2011-07-29 director
Hewlett Packard Enterprise Co 2023-01-10 director
Catalent Inc 2023-08-28 director

Frank A Damelio Latest Holdings Summary

Frank A Damelio currently owns a total of 3 stocks. Among these stocks, Frank A Damelio owns 337,392 shares of Pfizer Inc (PFE) as of July 2, 2019, with a value of $9 Million and a weighting of 54.16%. Frank A Damelio owns 20,634 shares of Humana Inc (HUM) as of July 29, 2011, with a value of $7 Million and a weighting of 41.28%. Frank A Damelio also owns 5,000 shares of Zoetis Inc (ZTS) as of February 6, 2013, with a value of $747,800 and a weighting of 4.56%.

Latest Holdings of Frank A Damelio

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PFE Pfizer Inc 2019-07-02 337,392 26.32 8,880,157
HUM Humana Inc 2011-07-29 20,634 327.98 6,767,539
ZTS Zoetis Inc 2013-02-06 5,000 149.56 747,800

Holding Weightings of Frank A Damelio


Frank A Damelio Form 4 Trading Tracker

According to the SEC Form 4 filings, Frank A Damelio has made a total of 1 transactions in Pfizer Inc (PFE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Pfizer Inc is the sale of 153,184 shares on July 2, 2019, which brought Frank A Damelio around $7 Million.

According to the SEC Form 4 filings, Frank A Damelio has made a total of 0 transactions in Humana Inc (HUM) over the past 5 years. The most-recent trade in Humana Inc is the acquisition of 526 shares on July 29, 2011, which cost Frank A Damelio around $41,991.

According to the SEC Form 4 filings, Frank A Damelio has made a total of 0 transactions in Zoetis Inc (ZTS) over the past 5 years. The most-recent trade in Zoetis Inc is the acquisition of 5,000 shares on February 6, 2013, which cost Frank A Damelio around $130,000.

Insider Trading History of Frank A Damelio

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Frank A Damelio Trading Performance

GuruFocus tracks the stock performance after each of Frank A Damelio's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frank A Damelio is 2.21%. GuruFocus also compares Frank A Damelio's trading performance to market benchmark return within the same time period. The performance of stocks bought by Frank A Damelio within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Frank A Damelio's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Frank A Damelio

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.18 2.21 -6.62 -16.18 8.77 15.25
Relative Return to S&P 500(%) 6.87 3.6 -0.91 -11.77 1.26 8.08

Frank A Damelio Ownership Network

Ownership Network List of Frank A Damelio

No Data

Ownership Network Relation of Frank A Damelio


Frank A Damelio Owned Company Details

What does Pfizer Inc do?

Who are the key executives at Pfizer Inc?

Frank A Damelio is the Senior Vice President of Pfizer Inc. Other key executives at Pfizer Inc include Executive Vice President Christoffel Boshoff , SVP & Controller Jennifer B. Damico , and Executive Vice President Payal Sahni .

Pfizer Inc () Insider Trades Summary

Over the past 18 months, Frank A Damelio made no insider transaction in Pfizer Inc (). Other recent insider transactions involving Pfizer Inc () include a net purchase of 5,000 shares made by Scott Gottlieb , and a net sale of 9,912 shares made by Jennifer B. Damico .

In summary, during the past 3 months, insiders sold 0 shares of Pfizer Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,912 shares of Pfizer Inc () were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 4,912 shares.

Pfizer Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Pfizer Inc Insider Transactions

No Available Data

Frank A Damelio Mailing Address

Above is the net worth, insider trading, and ownership report for Frank A Damelio. You might contact Frank A Damelio via mailing address: C/o Pfizer Inc., 235 East 42nd St., New York Ny 10017.

Discussions on Frank A Damelio

No discussions yet.